Between a third and half of the UK population didn’t receive the recommended number of Covid vaccinations and boosters by summer 2022, according to a study published in The Lancet.
All posts in vaccine
The COVID-19 vaccine saved over 1,000,000 lives across Europe between December 2020 and March 2023, according to new research presented at this year’s European Congress of Clinical Microbiology & Infectious
Patients suffering from autoimmune disorders — such as rheumatism, colitis, or psoriasis — may have to get a third vaccine against coronavirus to get enough protection, according to a study
Like Covid-19, the developing monkeypox outbreak likely had its origins in wild animals, following the pattern of an estimated 70 per cent of emerging diseases that cross between species. And while disease reservoirs in wild
As the EU continues its ongoing review of animal welfare legislation, one of the largest recorded outbreaks of bird flu is tearing through the poultry sector, forcing the pre-emptive culling
There is increasing evidence that the Omicron Covid variant is more infectious but less deadly than previous versions. Researchers believe this variant attacks mainly the throat but spares the lungs,
A team of UK and German researchers developed a new way to treat Alzheimer’s disease and potentially vaccinate against it, according to a study published in Molecular Psychiatry. This work
World awaits for temporary relaxation of intellectual property rights to vaccines against COVID-19
- Features -
Contrary to the position of the pharmaceutical industry, the procedures of forced transfer of licences should not be treated as a violation of patent rights, as they are, to a
“Europe must make progress on animal genomic editing.” Interview with J.P. Jégou, President of the French Veterinarian Academy”
- Research -
European Scientist was able to interview Jean-Pierre Jégou, President of the Académie Vétérinaire de France since the beginning of 2021, after five years as Secretary General, of this prestigious Academy
On Monday 21 December, the European Medicines Agency (EMA) recommended conditional approval for the use of the BioNTech-Pfizer coronavirus vaccine across the 27-nation EU bloc. The approval of the Amsterdam-based